ImageneBio, Inc. — Director's Dealing 2025

Jul 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ImageneBio, Inc. (IMA)
CIK: 0001835579
Period of Report: 2025-07-28

Reporting Person: Yarema Kristin (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-28	Employee Stock Option (Right to Buy)	$16.37	A	460515	Acquired	2035-07-27	Common Stock (460515)	Direct
2025-07-28	Restricted Stock Units	$	A	153505	Acquired		Common Stock (153505)	Direct

Footnotes

F1: This option vests over four years, with 25% of the shares subject to this option vesting on July 25, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter.

F2: Each restricted stock unit (collectively, the "RSUs") represents a contingent right to receive one share of the Issuer's common stock.

F3: The RSUs vest over four years, with 25% of the shares subject to RSUs vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in equal quarterly installments over the following 12 quarterly dates.